Prot# GS-US-227-0106: A Phase 2b, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of GS-9450 in Adults with Chronic Hepatitis C Virus Infection (GS-US-227-0106)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/17/096/17/12

Funding

  • Gilead Sciences, Inc. (GS-US-227-0106)